publication venue for
- The phase II/III transition. Toward the proof of efficacy in cancer clinical trials.. 21. 2000
- Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).. 20. 1999
- The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemia.. 17. 1996
- Suspended judgment. Significance tests of covariate imbalance in clinical trials.. 11. 1990
- The impact of treatment allocation procedures on nominal significance levels and bias.. 8. 1987
- Assessing patient comprehension of informed consent forms.. 25. 2004
- Ruminations on the intent-to-treat principle.. 21. 2000
- Do certain countries produce only positive results? A systematic review of controlled trials. 1998